Log In / Sign Up

SB 499

  • Wisconsin Senate Bill
  • 2021-2022 Regular Session
  • Introduced in Senate Aug 05, 2021
  • Senate
  • Assembly
  • Governor

Relating to: prescription drug cost reporting by manufacturers and providing a penalty.

View Latest Bill Text
Sign In to Follow

Abstract

Bill Sponsors (9)

Melissa Agard

  • Democratic
  • Senator
  • District 16
Primary

Jon Erpenbach

  • Democratic
Primary

LaTonya Johnson

  • Democratic
  • Senator
  • District 6
Primary

Janis Ringhand

  • Democratic
Primary

Tim Carpenter

  • Democratic
  • Senator
  • District 3
Primary

Chris Larson

  • Democratic
  • Senator
  • District 7
Primary

Brad Pfaff

  • Democratic
  • Senator
  • District 32
Primary

Bob Wirch

  • Democratic
  • Senator
  • District 22
Primary

Jeff Smith

  • Democratic
  • Senator
  • District 31
Primary

Votes

No votes to display

Actions

Mar 15, 2022

Senate

Failed to pass pursuant to Senate Joint Resolution 1

Aug 05, 2021

Senate

Introduced by Senators Agard, Erpenbach, Johnson, Ringhand, Carpenter, Larson, Pfaff, Wirch and Smith; cosponsored by Representatives Conley, Hebl, Snodgrass, Andraca, Neubauer, Shelton, Stubbs, Pope, Sinicki, Vruwink, Spreitzer, Vining, Cabral-Guevara, Bowen, S. Rodriguez and Shankland

Senate

Read first time and referred to Committee on Health

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2021 Assembly Bill 512 HTML
Wisconsin Ethics Commission information HTML
SB499 ROCP for Committee on Health HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.